BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghani R, Mullish BH, McDonald JAK, Ghazy A, Williams HRT, Brannigan ET, Mookerjee S, Satta G, Gilchrist M, Duncan N, Corbett R, Innes AJ, Pavlů J, Thursz MR, Davies F, Marchesi JR. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms. Clin Infect Dis 2021;72:1444-7. [PMID: 32681643 DOI: 10.1093/cid/ciaa948] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kenneally C, Murphy CP, Sleator RD, Culligan EP. The Urinary Microbiome and Biological Therapeutics: Novel Therapies For Urinary Tract Infections. Microbiological Research 2022. [DOI: 10.1016/j.micres.2022.127010] [Reference Citation Analysis]
2 Isles NS, Mu A, Kwong JC, Howden BP, Stinear TP. Gut microbiome signatures and host colonization with multidrug-resistant bacteria. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.013] [Reference Citation Analysis]
3 Khanna S. Microbiome-based Therapies for Multidrug-resistant Pathobionts: Getting a Step Closer! Clin Infect Dis 2021;72:1448-9. [PMID: 32681636 DOI: 10.1093/cid/ciaa943] [Reference Citation Analysis]
4 Baunwall SMD, Terveer EM, Dahlerup JF, Erikstrup C, Arkkila P, Vehreschild MJ, Ianiro G, Gasbarrini A, Sokol H, Kump PK, Satokari R, De Looze D, Vermeire S, Nakov R, Brezina J, Helms M, Kjeldsen J, Rode AA, Kousgaard SJ, Alric L, Trang-Poisson C, Scanzi J, Link A, Stallmach A, Kupcinskas J, Johnsen PH, Garborg K, Rodríguez ES, Serrander L, Brummer RJ, Galpérine KT, Goldenberg SD, Mullish BH, Williams HR, Iqbal TH, Ponsioen C, Kuijper EJ, Cammarota G, Keller JJ, Hvas CL. The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. Lancet Reg Health Eur 2021;9:100181. [PMID: 34693388 DOI: 10.1016/j.lanepe.2021.100181] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ghani R, Mullish BH, Davies FJ, Marchesi JR. How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection. Clin Microbiol Infect 2021:S1198-743X(21)00633-9. [PMID: 34826617 DOI: 10.1016/j.cmi.2021.11.006] [Reference Citation Analysis]
6 Macareño-castro J, Solano-salazar A, Dong LT, Mohiuddin M, Espinoza JL. Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.04.028] [Reference Citation Analysis]
7 Cold F, Svensson CK, Petersen AM, Hansen LH, Helms M. Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study. Cells 2022;11:435. [DOI: 10.3390/cells11030435] [Reference Citation Analysis]
8 Ghani R, Mullish BH, Roberts LA, Davies FJ, Marchesi JR. The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases. Gut Microbes 2022;14:2038856. [PMID: 35230889 DOI: 10.1080/19490976.2022.2038856] [Reference Citation Analysis]
9 Lu D, Huang Y, Kong Y, Tao T, Zhu X. Gut microecology: Why our microbes could be key to our health. Biomed Pharmacother 2020;131:110784. [PMID: 33152942 DOI: 10.1016/j.biopha.2020.110784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Pession A, Zama D, Muratore E, Leardini D, Gori D, Guaraldi F, Prete A, Turroni S, Brigidi P, Masetti R. Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review. J Pers Med 2021;11:100. [PMID: 33557125 DOI: 10.3390/jpm11020100] [Reference Citation Analysis]
11 Innes AJ, Mullish BH, Ghani R, Szydlo RM, Apperley JF, Olavarria E, Palanicawandar R, Kanfer EJ, Milojkovic D, McDonald JAK, Brannigan ET, Thursz MR, Williams HRT, Davies FJ, Marchesi JR, Pavlů J. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation. Front Cell Infect Microbiol 2021;11:684659. [PMID: 34513724 DOI: 10.3389/fcimb.2021.684659] [Reference Citation Analysis]
12 Ciftciler R, Ciftciler AE. The importance of microbiota in hematology. Transfus Apher Sci 2021;:103320. [PMID: 34801432 DOI: 10.1016/j.transci.2021.103320] [Reference Citation Analysis]
13 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]